Summary
- Current Price
- As of today, XFOR price is $4.13, up +1.10% on
- Current Price All-Time High
- XFOR price is currently -99.92% below its historical high of $5,164.92 set on
- Market Cap
- XFOR current market cap is $390M, up +2371.61% over the past 365 days
- PE Ratio
- XFOR PE ratio is unknown
- Revenue
- XFOR current annual revenue is $35.11M, up +1273.21% year-over-year
- Next Earnings
- The next earnings release for XFOR is on
Profile
| Metric | Value |
|---|---|
| Full Name | X4 Pharmaceuticals, Inc. |
| Ticker | NASDAQ: XFOR |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | x4pharma.com |
| Employees | 143 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $4.13 | ||
| Price, 1D Change | +1.10% | |
| $390M | ||
| - | ||
| - | ||
| 2.51 | ||
| $35M | ||
| Revenue, 1Y Change | +1,273.21% | |
| -$1.87 | ||
| EPS, 1Y Change | +66.49% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:30 | |
| Next Split | N/A | N/A |
| Last Ticker Change | ASNS | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.87 | ||
| EPS Estimate | N/A | -$0.76 |
| EPS Est. Change | N/A | +59.68% |
| $35.11M | ||
| Revenue Estimate | N/A | $9.50M |
| Revenue Est. Change | N/A | -72.94% |
| $4.13 | ||
| Price Target | - | $12.00 |
| Price Tgt. Change | - | +190.56% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.15 | -$5.59 | -3,564.13% | |
| -$2.40 | -$1.87 | +21.98% | |
| -$0.76 | N/A | +59.68% | |
| -$0.91 | N/A | +51.23% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.19M | $2.56M | +16.61% | |
| $34.24M | $35.11M | +2.54% | |
| $9.50M | N/A | -72.94% | |
| $9.58M | N/A | -72.73% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +108.59% | ||
| -92.90% | ||
| +2,371.61% | ||
| -95.93% | ||
| +1,273.21% | ||
| +100.00% | ||
| +66.49% | ||
| -23.38% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $4.13 | ||
| $3.80 | ||
| $4.09 | ||
| $4.44 | ||
| $4.06 | ||
| $0.05 | ||
| 2.51 | ||
| $0.27 | ||
| 51.05 | ||
| 96.93% | ||
| 124.86% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $35.11M | ||
| -$1.87 | ||
| $28.86M | ||
| 82.18% | ||
| -$86.88M | ||
| -247.44% | ||
| -$79.20M | ||
| -225.55% | ||
| -$85.61M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.41 | ||
| 10.15 | ||
| 9.97 | ||
| - | ||
| 3 | ||
| -0.51 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 43.22 | ||
| 2.31 | ||
| -2.41 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $186.29M | ||
| $253.80M | ||
| $290.46M | ||
| $261.38M | ||
| $104.17M | ||
| $25.76M | ||
| $77.29M | ||
| $994.00K | ||
| $5.70M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $114.31M | ||
| $115.74M | ||
| $6.26M | ||
| $0.00 | ||
| $1.28M | ||
| $0.00 | ||
| $41.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$85.62M | ||
| $8.15M | ||
| $238.63M | ||
| $3.00M | ||
| -$88.62M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Leerink Partners | ||
| Guggenheim | ||
| Stifel | → | |
| HC Wainwright & Co. | → | |
| Stifel | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Cantor Fitzgerald | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with XFOR
FAQ
What is the ticker symbol for X4 Pharmaceuticals, Inc.?
The ticker symbol for X4 Pharmaceuticals, Inc. is NASDAQ:XFOR
Does X4 Pharmaceuticals, Inc. pay dividends?
No, X4 Pharmaceuticals, Inc. does not pay dividends
What sector is X4 Pharmaceuticals, Inc. in?
X4 Pharmaceuticals, Inc. is in the Healthcare sector
What industry is X4 Pharmaceuticals, Inc. in?
X4 Pharmaceuticals, Inc. is in the Biotechnology industry
What country is X4 Pharmaceuticals, Inc. based in?
X4 Pharmaceuticals, Inc. is headquartered in United States
When did X4 Pharmaceuticals, Inc. go public?
X4 Pharmaceuticals, Inc. initial public offering (IPO) was on November 16, 2017
Is X4 Pharmaceuticals, Inc. in the S&P 500?
No, X4 Pharmaceuticals, Inc. is not included in the S&P 500 index
Is X4 Pharmaceuticals, Inc. in the NASDAQ 100?
No, X4 Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is X4 Pharmaceuticals, Inc. in the Dow Jones?
No, X4 Pharmaceuticals, Inc. is not included in the Dow Jones index
When was X4 Pharmaceuticals, Inc. last earnings report?
X4 Pharmaceuticals, Inc.'s most recent earnings report was on May 6, 2026
When does X4 Pharmaceuticals, Inc. report earnings?
The next expected earnings date for X4 Pharmaceuticals, Inc. is August 6, 2026
Data Sources & References
- XFOR Official Website www.x4pharma.com
- XFOR Profile on Yahoo Finance finance.yahoo.com/quote/XFOR
- XFOR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/xfor